Neurological Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting; Correction
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of Friday, December 7, 2012 (77 FR 73034). The product name in the document was incorrect. This document corrects that error.
Table of Contents Back to Top
FOR FURTHER INFORMATION CONTACT: Back to Top
Natasha Facey, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993, 301-796-5290, Natasha.Facey@fda.hhsgov.
SUPPLEMENTARY INFORMATION: Back to Top
In FR doc. 2012-29538, appearing on page 73034 in the Federal Register of Friday, December 7, 2012, the following correction is made:
1. On page 73034, in the second column under the section entitled “Agenda”, the product name “NeuroPace Responsive Neurostimulation (RNS) System” is corrected to read “NeuroPace RNS System”.
Dated: December 7, 2012.
Jill Hartzler Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2012-30024 Filed 12-12-12; 8:45 am]
BILLING CODE 4160-01-P